Logo image of GPRE

GREEN PLAINS INC (GPRE) Stock Fundamental Analysis

NASDAQ:GPRE - Nasdaq - US3932221043 - Common Stock - Currency: USD

4.21  -0.22 (-4.97%)

After market: 4.21 0 (0%)

Fundamental Rating

2

GPRE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 213 industry peers in the Oil, Gas & Consumable Fuels industry. GPRE has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, GPRE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GPRE has reported negative net income.
GPRE had a negative operating cash flow in the past year.
In the past 5 years GPRE always reported negative net income.
GPRE had a positive operating cash flow in 4 of the past 5 years.
GPRE Yearly Net Income VS EBIT VS OCF VS FCFGPRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

GPRE has a Return On Assets of -6.24%. This is in the lower half of the industry: GPRE underperforms 77.93% of its industry peers.
GPRE has a Return On Equity of -13.04%. This is in the lower half of the industry: GPRE underperforms 74.65% of its industry peers.
Industry RankSector Rank
ROA -6.24%
ROE -13.04%
ROIC N/A
ROA(3y)-5.15%
ROA(5y)-5.08%
ROE(3y)-11.53%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A
GPRE Yearly ROA, ROE, ROICGPRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15 -20

1.3 Margins

GPRE has a Gross Margin of 5.19%. This is in the lower half of the industry: GPRE underperforms 75.59% of its industry peers.
GPRE's Gross Margin has improved in the last couple of years.
GPRE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.46%
GM growth 5Y30.95%
GPRE Yearly Profit, Operating, Gross MarginsGPRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

More info and screens

1

2. Health

2.1 Basic Checks

GPRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
GPRE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, GPRE has more shares outstanding
Compared to 1 year ago, GPRE has a worse debt to assets ratio.
GPRE Yearly Shares OutstandingGPRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
GPRE Yearly Total Debt VS Total AssetsGPRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 1.28, we must say that GPRE is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.28, GPRE is in line with its industry, outperforming 52.11% of the companies in the same industry.
A Debt/Equity ratio of 0.71 indicates that GPRE is somewhat dependend on debt financing.
GPRE's Debt to Equity ratio of 0.71 is on the low side compared to the rest of the industry. GPRE is outperformed by 62.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z 1.28
ROIC/WACCN/A
WACC8.02%
GPRE Yearly LT Debt VS Equity VS FCFGPRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

GPRE has a Current Ratio of 1.38. This is a normal value and indicates that GPRE is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.38, GPRE is doing good in the industry, outperforming 63.38% of the companies in the same industry.
GPRE has a Quick Ratio of 1.38. This is a bad value and indicates that GPRE is not financially healthy enough and could expect problems in meeting its short term obligations.
GPRE has a worse Quick ratio (0.81) than 61.03% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.81
GPRE Yearly Current Assets VS Current LiabilitesGPRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

GPRE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.40%.
The Revenue for GPRE has decreased by -19.51% in the past year. This is quite bad
GPRE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.34% yearly.
EPS 1Y (TTM)-37.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40.74%
Revenue 1Y (TTM)-19.51%
Revenue growth 3Y-4.55%
Revenue growth 5Y0.34%
Sales Q2Q%0.72%

3.2 Future

Based on estimates for the next years, GPRE will show a very strong growth in Earnings Per Share. The EPS will grow by 57.49% on average per year.
GPRE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.70% yearly.
EPS Next Y21.93%
EPS Next 2Y50.94%
EPS Next 3Y43.09%
EPS Next 5Y57.49%
Revenue Next Year-0.2%
Revenue Next 2Y1.32%
Revenue Next 3Y8.55%
Revenue Next 5Y8.7%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GPRE Yearly Revenue VS EstimatesGPRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
GPRE Yearly EPS VS EstimatesGPRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 10

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

GPRE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 11.12, which indicates a very decent valuation of GPRE.
GPRE's Price/Forward Earnings ratio is in line with the industry average.
GPRE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 11.12
GPRE Price Earnings VS Forward Price EarningsGPRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

74.18% of the companies in the same industry are cheaper than GPRE, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 57.58
GPRE Per share dataGPRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

GPRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GPRE's earnings are expected to grow with 43.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.94%
EPS Next 3Y43.09%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GPRE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREEN PLAINS INC

NASDAQ:GPRE (5/23/2025, 5:20:01 PM)

After market: 4.21 0 (0%)

4.21

-0.22 (-4.97%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners100.26%
Inst Owner Change-7.13%
Ins Owners2.05%
Ins Owner Change3.19%
Market Cap275.29M
Analysts72.5
Price Target9.86 (134.2%)
Short Float %13.05%
Short Ratio3.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.08
Dividend Growth(5Y)-36.76%
DP-4.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-133.26%
Min EPS beat(2)-165.14%
Max EPS beat(2)-101.38%
EPS beat(4)1
Avg EPS beat(4)-29.33%
Min EPS beat(4)-213.36%
Max EPS beat(4)362.54%
EPS beat(8)2
Avg EPS beat(8)-968.52%
EPS beat(12)3
Avg EPS beat(12)-729.5%
EPS beat(16)4
Avg EPS beat(16)-588.94%
Revenue beat(2)0
Avg Revenue beat(2)-5.86%
Min Revenue beat(2)-9.38%
Max Revenue beat(2)-2.34%
Revenue beat(4)0
Avg Revenue beat(4)-5.2%
Min Revenue beat(4)-9.38%
Max Revenue beat(4)-2.34%
Revenue beat(8)2
Avg Revenue beat(8)-3.87%
Revenue beat(12)5
Avg Revenue beat(12)-1.6%
Revenue beat(16)9
Avg Revenue beat(16)0.05%
PT rev (1m)-13%
PT rev (3m)-52.55%
EPS NQ rev (1m)-13.46%
EPS NQ rev (3m)-63.89%
EPS NY rev (1m)-31.27%
EPS NY rev (3m)-157.04%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)-1.36%
Revenue NY rev (1m)-0.82%
Revenue NY rev (3m)-8.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.12
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.35
P/tB 0.35
EV/EBITDA 57.58
EPS(TTM)-1.69
EYN/A
EPS(NY)0.38
Fwd EY8.99%
FCF(TTM)-1.9
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS37.67
BVpS12.2
TBVpS12.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.24%
ROE -13.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.19%
FCFM N/A
ROA(3y)-5.15%
ROA(5y)-5.08%
ROE(3y)-11.53%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.46%
GM growth 5Y30.95%
F-Score2
Asset Turnover1.48
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA 52.45
Cap/Depr 98.37%
Cap/Sales 3.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 0.81
Altman-Z 1.28
F-Score2
WACC8.02%
ROIC/WACCN/A
Cap/Depr(3y)148.04%
Cap/Depr(5y)157.81%
Cap/Sales(3y)4.32%
Cap/Sales(5y)5.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40.74%
EPS Next Y21.93%
EPS Next 2Y50.94%
EPS Next 3Y43.09%
EPS Next 5Y57.49%
Revenue 1Y (TTM)-19.51%
Revenue growth 3Y-4.55%
Revenue growth 5Y0.34%
Sales Q2Q%0.72%
Revenue Next Year-0.2%
Revenue Next 2Y1.32%
Revenue Next 3Y8.55%
Revenue Next 5Y8.7%
EBIT growth 1Y-45.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year196.53%
EBIT Next 3Y86.55%
EBIT Next 5Y63.88%
FCF growth 1Y-83.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-129.87%
OCF growth 3YN/A
OCF growth 5YN/A